2003
Off-Pump System Enhances Access and Visibility at Bypass Graft Connection Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Next-Generation Drug Eluting Stent Utilizes Guidant''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Next Generation Device Designed to Address Common Co-morbidity for Heart Failure Patients Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
Legislation Benefits Patients, Physicians and Medical Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Company Reiterates 2005 Introduction of First Drug Eluting Stent New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today is providing a...
Company Reiterates Guidance for 2003; Previews 2004 Full-Year Revenue and Earnings New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will...
New Investments and Sponsorships Bolster Guidant''s Commitment to Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Strategic alliance allows for sharing of data and systems Milwaukee, Wis. and St. Paul, Minn. - GE Medical Systems, a division of the General Electric Company (NYSE: GE) and Guidant Corporation...
RELIANCE G Leads are First to Feature Covering to Prevent Tissue Ingrowth Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
NSIGNIA Ultra''s Unique Technology Enables Tailored Therapy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...